Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Life Science Giant PPD Cuts an Undisclosed Number of Jobs

CRO giant Pharmaceutical Product Development LLC terminated a number of employees in its human resources department, but has provided few details about the job cuts, according to reports.

Read More »

W2O Group Expands Chicago Presence

W2O Group, a network of innovative analytics-driven, digital-first marketing and communications firms, announced the appointment of three senior executives in its growing Chicago office.

Read More »

GSK appoints new R&D head

GlaxoSmithKline poached veteran drug industry scientist Hal Barron from Alphabet-funded Calico to be its research head.

Read More »

Mario Muredda Named CEO of Harrison and Star

Omnicom Health Group announced that Mario Muredda has been named CEO of Harrison and Star and former CEO Ty Curran has been promoted to chairman. The changes are effective January 1, 2018.

Read More »

Kirsten A. Kantak Appointed CEO of Biolumina

Omnicom Health Group announced that Kirsten A. Kantak was appointed CEO of Biolumina.

Read More »

X-Spine Systems to Shut Down, Lays Off 54 Employees

X-Spine Systems, a division of Xtant Medical Systems, is shutting down a facility in Ohio and terminating 54 people between December and February 2018.

Read More »

Merck to Cut 1,800 Jobs and Add 960 in Chronic Care

As part of a new sales team structure, Merck plans to cut 1,800 sales jobs. At the same time, the company expects to add 960 jobs to a new sales force focused on chronic care.

Read More »

450 Jobs Eliminated as Novartis Shuts Down Colorado Facility

Switzerland-based Novartis is closing the company’s generic-drug manufacturing facility in Broomfield, Colo., which will cut 450 jobs over two years.

Read More »

Massachusetts’ Biostage Slashes 71 Percent of Staff, Evaluating Strategic Alternatives

An investor decision to renege on acquiring more than $3 million worth of stock has created a financial catastrophe for Biostage Inc. To maintain operations, the company is terminating 17 employees, about 71 percent of its workforce.

Read More »

Ardelyx Shares Soared After Positive Phase III Results for Tenapanor

Two months after slashing 28 percent of its workforce as part of a strategic review, Ardelyx Inc. announced positive Phase III results for tenapanor, its irritable bowel syndrome with constipation (IBS-C).

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom